Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nelson N Stone

Showing results (91-100 of 120) with videos related to

Pageof 12
Sort By:
BJU International|April 21, 2005
C-reactive protein is significantly associated with prostate-specific antigen and metastatic disease in prostate cancerSteven Lehrer, Edward J Diamond, Boris Mamkine, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2010
Young men have equivalent biochemical outcomes compared with older men after treatment with brachytherapy for prostate cancerRyan J Burri, Alice Y Ho, Kevin Forsythe, et al.
Technology in Cancer Research & Treatment|October 7, 2016
Deflection Analysis of Different Needle Designs for Prostate Biopsy and Focal TherapyNelson N Stone, Vladimir Mouraviev, David Schechter, et al.
Brachytherapy|February 8, 2007
Is seminal vesicle implantation with permanent sources possible? A dose-volume histogram analysis in patients undergoing combined 103Pd implantation and external beam radiation for T3c prostate cancerAlice Y Ho, Ryan J Burri, Glenn T Jennings, et al.
Urology Practice|August 4, 2023
Moving Forward the State of the Art in Prostate Cancer Treatment: Targeted Focal TherapyE David Crawford, Kyle O Rove, Nelson N Stone, et al.
Urologic Oncology|July 15, 2003
Elevated serum triiodothyronine (t3) in Ashkenazi Jewish prostate cancer patients carrying the I1307k allele of the APC (adenopolyposis coli) geneSteven Lehrer, Edward J Diamond, Nelson N Stone, et al.
Reviews in Urology|June 27, 2018
Transrectal Ultrasound-guided Versus Transperineal Mapping Prostate Biopsy: Complication ComparisonVassilios M Skouteris, E David Crawford, Vladimir Mouraviev, et al.
Brachytherapy|January 22, 2020
Prolonged hormonal therapy and external beam radiation independently increase the risk of Persistent Hypogonadism in men treated with prostate brachytherapyKyrollis Attalla, Daniel Sagalovich, Kathryn E Marqueen, et al.
BMC Cancer|March 24, 2012
Tri-Modality therapy with I-125 brachytherapy, external beam radiation therapy, and short- or long-term hormone therapy for high-risk localized prostate cancer (TRIP): study protocol for a phase III, multicenter, randomized, controlled trialHiroyuki Konaka, Shin Egawa, Shiro Saito, et al.
The Journal of Urology|March 6, 2019
The Ratio of the Number of Biopsy Specimens to Prostate Volume (Biopsy Density) Greater Than 1.5 Improves the Prostate Cancer Detection Rate in Men Undergoing Transperineal Biopsy of the ProstateNelson N Stone, E David Crawford, Vassilios M Skouteris, et al.
Pageof 12

Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
BJU International|April 21, 2005
C-reactive protein is significantly associated with prostate-specific antigen and metastatic disease in prostate cancerSteven Lehrer, Edward J Diamond, Boris Mamkine, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2010
Young men have equivalent biochemical outcomes compared with older men after treatment with brachytherapy for prostate cancerRyan J Burri, Alice Y Ho, Kevin Forsythe, et al.
Technology in Cancer Research & Treatment|October 7, 2016
Deflection Analysis of Different Needle Designs for Prostate Biopsy and Focal TherapyNelson N Stone, Vladimir Mouraviev, David Schechter, et al.
Brachytherapy|February 8, 2007
Is seminal vesicle implantation with permanent sources possible? A dose-volume histogram analysis in patients undergoing combined 103Pd implantation and external beam radiation for T3c prostate cancerAlice Y Ho, Ryan J Burri, Glenn T Jennings, et al.
Urology Practice|August 4, 2023
Moving Forward the State of the Art in Prostate Cancer Treatment: Targeted Focal TherapyE David Crawford, Kyle O Rove, Nelson N Stone, et al.
Urologic Oncology|July 15, 2003
Elevated serum triiodothyronine (t3) in Ashkenazi Jewish prostate cancer patients carrying the I1307k allele of the APC (adenopolyposis coli) geneSteven Lehrer, Edward J Diamond, Nelson N Stone, et al.
Reviews in Urology|June 27, 2018
Transrectal Ultrasound-guided Versus Transperineal Mapping Prostate Biopsy: Complication ComparisonVassilios M Skouteris, E David Crawford, Vladimir Mouraviev, et al.
Brachytherapy|January 22, 2020
Prolonged hormonal therapy and external beam radiation independently increase the risk of Persistent Hypogonadism in men treated with prostate brachytherapyKyrollis Attalla, Daniel Sagalovich, Kathryn E Marqueen, et al.
BMC Cancer|March 24, 2012
Tri-Modality therapy with I-125 brachytherapy, external beam radiation therapy, and short- or long-term hormone therapy for high-risk localized prostate cancer (TRIP): study protocol for a phase III, multicenter, randomized, controlled trialHiroyuki Konaka, Shin Egawa, Shiro Saito, et al.
The Journal of Urology|March 6, 2019
The Ratio of the Number of Biopsy Specimens to Prostate Volume (Biopsy Density) Greater Than 1.5 Improves the Prostate Cancer Detection Rate in Men Undergoing Transperineal Biopsy of the ProstateNelson N Stone, E David Crawford, Vassilios M Skouteris, et al.
Pageof 12